Extracellular Vesicles for the Treatment of Syringomyelia

Biological/cell based
General health
Online since 1 April 2026, updated 9 days ago

About this trial

This Phase I trial is enrolling 18 participants with syringomyelia to evaluate the safety and efficacy of spinal injection of molecules derived from human umbilical cord blood stem cells. These molecules are thought to improve nerve cell signaling. Syringomyelia is a condition in which a fluid-filled cavity forms within the spinal cord, which can damage spinal cord tissue and lead to pain or sensory loss. If included, participants will receive monthly injections into the spinal canal for three months, with escalating dose levels evaluated sequentially for safety. Final assessment of safety will be performed after 1 year.

Included participants

Gender
All
Age
18 - 60 years
Injury level
C1 - S5
  • Severity (AIS)?
  • Time since injury
    All
    Healthy volunteers
    No
    C1-S5

    What’s involved

    Type

    Biological/cell based

    Details

    - Participants will receive monthly injections of extracellular vesicles derived from human umbilical cord blood mesenchymal stem cells into the spinal canal for three months, with escalating dose levels evaluated sequentially for safety. - These extracellular vesicles (tiny particles) are thought to improve nerve cell signaling. - Syringomyelia is a condition in which a fluid-filled cavity forms within the spinal cord, which can damage spinal cord tissue and lead to pain or sensory loss. - Final assessment of safety will be performed after 1 year.

    Potential benefits

    Main benefits

    General health

    Additional benefits

    Arm/hand function

    Sensory function

    Standing/walking/mobility

    Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.

    Wings for Life supports SCITrialsFinder

    Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.

    Learn more


    • Trial recruitment status
    • Recruiting
    • Trial start date
    • 23 Dec 2025
    • Organisation
    • Xuanwu Hospital, Beijing
    • Trial recruitment status
    • Recruiting
    • Trial start date
    • 23 Dec 2025
    • Organisation
    • Xuanwu Hospital, Beijing

    Wings for Life supports SCITrialsFinder

    Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.

    Learn more